Fresenius Medical Care AG & Co. KGaA (FMS) To Go Ex-Dividend on May 22nd

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) declared an annual dividend on Friday, May 1st. Stockholders of record on Friday, May 22nd will be given a dividend of 0.8716 per share on Monday, June 8th. This represents a dividend yield of 385.0%. The ex-dividend date is Friday, May 22nd. This is a 10.7% increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79.

Fresenius Medical Care AG & Co. KGaA has raised its dividend by an average of 0.0%annually over the last three years. Fresenius Medical Care AG & Co. KGaA has a dividend payout ratio of 25.8% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Fresenius Medical Care AG & Co. KGaA to earn $2.43 per share next year, which means the company should continue to be able to cover its $0.61 annual dividend with an expected future payout ratio of 25.1%.

Fresenius Medical Care AG & Co. KGaA Stock Performance

Shares of Fresenius Medical Care AG & Co. KGaA stock opened at $22.12 on Wednesday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.86 and a current ratio of 1.20. Fresenius Medical Care AG & Co. KGaA has a one year low of $20.02 and a one year high of $30.46. The company has a market cap of $12.36 billion, a PE ratio of 11.64, a P/E/G ratio of 4.01 and a beta of 0.81. The business has a 50-day simple moving average of $22.47 and a 200-day simple moving average of $23.14.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%.The firm had revenue of $5.34 billion for the quarter. On average, equities research analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on FMS. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, May 7th. Citigroup reaffirmed a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Friday, April 24th. Wall Street Zen cut Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Erste Group Bank downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 5th. Finally, Jefferies Financial Group raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research report on Friday, May 8th. Five equities research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.